Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)

Clinical trial NCT00424177 · COMPLETED

Trial details

NCT number: NCT00424177
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Purpura, Thrombocytopaenic, Idiopathic

Start date: 2007-03-01
Primary completion: 2008-08-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.